These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12845860)

  • 1. [Correct diagnosis. Obstinate high blood pressure unmasked].
    Stiefelhagen P
    MMW Fortschr Med; 2003 May; 145(21):14. PubMed ID: 12845860
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary hyperaldosteronism in a patient with end-stage renal disease.
    Kazory A; Weiner ID
    Nephrol Dial Transplant; 2007 Mar; 22(3):917-9. PubMed ID: 17127694
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
    Reincke M
    MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis and treatment of primary hyperaldosteronism].
    Vetshev SP; Polunin GV; Sotnikova VA
    Khirurgiia (Mosk); 2004; (3):61-9. PubMed ID: 15359491
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
    Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
    Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensives.
    Cranwell-Bruce LA
    Medsurg Nurs; 2008 Oct; 17(5):337-41; quiz 342. PubMed ID: 19051983
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldosteronism and hypertension.
    Calhoun DA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1039-45. PubMed ID: 17699324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral adrenal cortical hyperplasia.
    Slifer A; Aronoff DM
    Tenn Med; 2000 May; 93(5):172-3. PubMed ID: 10821072
    [No Abstract]   [Full Text] [Related]  

  • 9. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
    Gaddam KK; Pratt-Ubunama MN; Calhoun DA
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):353-9. PubMed ID: 16716096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hyperaldosteronism as a cause of hypertension; diagnosis].
    Conchillo JM; Bravenboer B
    Ned Tijdschr Geneeskd; 1996 Jun; 140(25):1329. PubMed ID: 8710017
    [No Abstract]   [Full Text] [Related]  

  • 11. [How to unravel hyperaldosteronism in clinical practice].
    van der Giet M
    MMW Fortschr Med; 2014 Oct; 156(17):61-2. PubMed ID: 25417478
    [No Abstract]   [Full Text] [Related]  

  • 12. Are hypertension and bypass linked?
    Kochar MS
    Postgrad Med; 2004 Apr; 115(4):8. PubMed ID: 15095531
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of inactive adrenal node that transformed to adenoma with manifestations of primary hyperaldosteronism in a patient with essential hypertension].
    Hatzitolios A; Delivoria C; Karabatsu S; Savopoulos C; Karamuzia M; Tsatidis R; Tataridis A; Kartavenko IM
    Klin Med (Mosk); 2004; 82(9):67-8. PubMed ID: 15540428
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trends in the differential diagnosis of arterial hypertension].
    Beretta Anguissola A; Campus S
    Cardiol Prat; 1968 Dec; 19(6):463-70. PubMed ID: 5718158
    [No Abstract]   [Full Text] [Related]  

  • 15. [The angiotensin test in the diagnosis of renovascular hypertension].
    Verzetti G; Busilacchi M; Perpignano G
    Minerva Nefrol; 1967; 14(2):65-7. PubMed ID: 4301734
    [No Abstract]   [Full Text] [Related]  

  • 16. [Importance of Kaplan's hypertension testing the etiologic diagnosis of hypertension].
    Cottier P; Wettstein R; Veyrat R; Reubi F
    Helv Med Acta Suppl; 1966 May; 46():140. PubMed ID: 4329276
    [No Abstract]   [Full Text] [Related]  

  • 17. [Normokalemic primary hyperaldosteronism].
    Vonend O; Rump LC
    Dtsch Med Wochenschr; 2006 Nov; 131(46 Spec No):H24-7. PubMed ID: 17109245
    [No Abstract]   [Full Text] [Related]  

  • 18. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
    Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New potentialities in the treatment of idiopathic hyperaldosteronism].
    Podzolkov VI; Rodionov AV
    Klin Med (Mosk); 2004; 82(6):34-8. PubMed ID: 15344688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.